NON INVASIVE PRENATAL TESTING (NIPT)

The NON INVASIVE PRENATAL TESTING (NIPT) is an advanced screening test offered during pregnancy to assess the likelihood of certain chromosomal abnormalities in the developing baby. Unlike invasive diagnostic tests like amniocentesis or chorionic villus sampling (CVS), NIPT requires only a simple blood sample from the mother, making it a safe option for both mother and baby.

Its role in early prenatal care is significant. By analyzing tiny fragments of the baby's DNA (cell-free DNA or cfDNA) that circulate in the mother's bloodstream, NIPT can provide valuable insights early in pregnancy, typically from 10 weeks gestation. This information can help expectant parents and their healthcare providers make informed decisions about further testing and pregnancy management.

It's crucial to understand that NON INVASIVE PRENATAL TESTING (NIPT) is a screening test, not a diagnostic test. This means it indicates the probability or risk of a specific condition being present. A high-risk result suggests an increased chance and warrants further discussion and usually, confirmatory diagnostic testing. Conversely, a low-risk result significantly reduces the likelihood of these conditions but does not eliminate it entirely.

The potential for NIPT to provide early insights can also help parents prepare emotionally and practically for their baby's arrival. For some, this early information can ease anxiety related to the unknown and foster early parent-child bonding through informed expectations and planning. At Cadabams Diagnostics, we are committed to providing you with clear information about your NON INVASIVE PRENATAL TESTING (NIPT) options.

The NON INVASIVE PRENATAL TESTING (NIPT) primarily measures the amount of fetal cell-free DNA (cfDNA) present in the mother's blood. This cfDNA originates mainly from the placenta and carries genetic information about the fetus. The proportion of fetal cfDNA compared to maternal cfDNA is known as the "fetal fraction," which is an important factor for the accuracy of the test.

Specifically, NIPT screens for common chromosomal aneuploidies, which are conditions caused by an abnormal number of chromosomes. These include:

• Trisomy 21 (Down syndrome): Caused by an extra copy of chromosome 21.
• Trisomy 18 (Edwards syndrome): Caused by an extra copy of chromosome 18.
• Trisomy 13 (Patau syndrome): Caused by an extra copy of chromosome 13.

This answers a key question many parents have: what does non invasive prenatal testing screen for? Beyond these common trisomies, NIPT may also offer screening for:

• Sex Chromosome Aneuploidies: Conditions involving an abnormal number of X or Y chromosomes, such as Turner syndrome (Monosomy X), Klinefelter syndrome (XXY), Triple X syndrome (XXX), and Jacobs syndrome (XYY).
• Fetal Sex Determination: NIPT can also determine the baby's sex with high accuracy, if this information is desired by the parents and offered as part of the test panel at Cadabams Diagnostics.

It is important to discuss with your healthcare provider at Cadabams Diagnostics which specific conditions are included in the NON INVASIVE PRENATAL TESTING (NIPT) panel offered.

The NON INVASIVE PRENATAL TESTING (NIPT) is typically offered to pregnant women from 10 weeks of gestation onwards. There needs to be a sufficient amount of fetal cfDNA in the maternal bloodstream for the test to be accurate, and this level is generally reached by the 10-week mark.

There are several reasons why an expectant mother might opt for NIPT:

• Advanced Maternal Age: Women aged 35 and older at the time of delivery have a higher chance of having a baby with certain chromosomal abnormalities.
• Previous Pregnancy with a Chromosomal Abnormality: A history of a previous pregnancy affected by a trisomy increases the risk for future pregnancies.
• Abnormal Ultrasound Findings: Certain findings on an ultrasound scan (e.g., increased nuchal translucency) may suggest an increased risk of chromosomal conditions.
• Positive First or Second Trimester Screening Results: If traditional maternal serum screening tests (like the double marker or quadruple marker test) indicate an increased risk, NIPT can be offered as a more accurate follow-up screening test.
• Patient Preference after Counselling: Some individuals, after comprehensive counselling about prenatal screening options, may choose NIPT for its higher accuracy and lower false-positive rate compared to traditional screening methods, even without specific risk factors.

NIPT fits into the prenatal screening pathway as an advanced, highly accurate screening tool. It can help refine risk assessment and reduce the number of women who undergo invasive diagnostic procedures unnecessarily. Your doctor at Cadabams Diagnostics will help you understand if and when NON INVASIVE PRENATAL TESTING (NIPT) is appropriate for you.

One of the significant advantages of the NON INVASIVE PRENATAL TESTING (NIPT) is its safety profile. The physical risk is minimal, equivalent to that of any standard blood draw, which includes a small chance of bruising, discomfort at the needle site, or, rarely, fainting or infection.

However, it's essential to understand the limitations of NIPT:

• Screening, Not Diagnostic: This is a critical point. NIPT assesses risk; it does not provide a definitive diagnosis. A "high-risk" result from NIPT indicates an increased likelihood of a chromosomal abnormality and means that confirmatory diagnostic testing, such as amniocentesis or chorionic villus sampling (CVS), is recommended. These diagnostic tests analyze fetal cells directly and provide a definitive answer but carry a small risk of miscarriage.
• False Positives and False Negatives: While the NIPT test accuracy and reliability are very high for the conditions it screens for (especially Down syndrome), false positives (test indicates high risk, but the baby is unaffected) and false negatives (test indicates low risk, but the baby is affected) can occur, though rarely.
• Factors Affecting Test Accuracy:
• Low Fetal Fraction: If the amount of fetal cfDNA in the mother's blood is too low (e.g., due to early gestational age, high maternal body mass index, or certain placental issues), the test may not yield a result ("no-call" result) or its accuracy might be reduced.
• Maternal Conditions: Certain maternal health conditions, including cancer, autoimmune diseases, or a history of organ transplant, can interfere with NIPT results.
• Vanishing Twin: If one twin demises early in a multiple pregnancy, DNA from that twin might still be present and could affect the results.
• Placental Mosaicism: Sometimes, the chromosomal makeup of the placenta (from which cfDNA originates) differs from that of the fetus. This can lead to discordant NIPT results.
• Certain Types of Twin Pregnancies: Accuracy may vary for certain types of twin or higher-order multiple pregnancies.

Understanding these limitations, along with the benefits, is part of considering the NIPT pros and cons. A detailed discussion with your healthcare provider at Cadabams Diagnostics or a genetic counselor is vital before deciding to proceed with NON INVASIVE PRENATAL TESTING (NIPT).

The results of a NON INVASIVE PRENATAL TESTING (NIPT) report typically include several key parameters:

• Risk Scores/Assessment for Specific Trisomies:
• Trisomy 21 (Down syndrome): Reported as "low risk" or "high risk" (or similar terminology indicating the probability).
• Trisomy 18 (Edwards syndrome): Reported as "low risk" or "high risk."
• Trisomy 13 (Patau syndrome): Reported as "low risk" or "high risk."
• Fetal Fraction Percentage: This is the percentage of fetal cfDNA detected in the maternal blood sample. A certain minimum fetal fraction (e.g., often around 4%) is required for a reliable NIPT result. If the fetal fraction is too low, a repeat sample may be requested, or the test may be reported as "no-call."
• Results for Sex Chromosome Aneuploidies (if included in the panel): If screened for, conditions like Turner syndrome (XO), Klinefelter syndrome (XXY), Triple X (XXX), or Jacobs syndrome (XYY) will be reported, often as "aneuploidy suspected" or "no aneuploidy detected."
• Fetal Sex (if requested/reported): If the parents have requested to know the fetal sex, and the test panel includes this, it will be reported (e.g., Male/Female).

Some NIPT panels might also screen for specific microdeletion syndromes, which are conditions caused by a small missing piece of a chromosome. Early identification of certain genetic conditions can be important, as some may be associated with a higher likelihood of developmental delay. This early awareness allows parents and healthcare providers to plan for any necessary specialized care or interventions. Your healthcare provider at Cadabams Diagnostics can explain the specific parameters included in your NON INVASIVE PRENATAL TESTING (NIPT).

While NON INVASIVE PRENATAL TESTING (NIPT) can be offered to many pregnant individuals, certain groups might particularly benefit from considering this advanced screening:

• Pregnant individuals seeking detailed information about their baby's risk for common fetal chromosomal abnormalities.
• Those with increased risk factors, including:
• Advanced maternal age (35 years or older at expected delivery).
• A personal or family history of a previous pregnancy affected by a chromosomal condition.
• Abnormal findings on a prenatal ultrasound suggestive of aneuploidy (e.g., increased nuchal translucency, structural anomalies).
• A positive (high-risk) result from traditional first-trimester or second-trimester screening tests (e.g., double marker, quadruple marker).
• Individuals who desire higher detection rates and lower false-positive rates for common trisomies compared to traditional serum screening methods. NIPT generally offers superior accuracy for these conditions.
• Those who wish to avoid invasive diagnostic testing (like amniocentesis or CVS) if possible, by first opting for a highly accurate screening test. A low-risk NIPT result can provide significant reassurance and may reduce the need for such procedures.

Ultimately, the decision to undertake NON INVASIVE PRENATAL TESTING (NIPT) is a personal one. A thorough discussion with your healthcare provider at Cadabams Diagnostics or a is crucial. They can review your individual risk factors, explain the test in detail, and help you determine if NIPT is the right choice for your prenatal care journey.

Choosing to undergo NON INVASIVE PRENATAL TESTING (NIPT) at Cadabams Diagnostics offers several significant advantages for expectant parents:

• High Accuracy for Specific Conditions: One of the foremost benefits is the high NIPT test accuracy and reliability, especially for Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). Detection rates are typically greater than 99% for Down syndrome, with very low false-positive rates (often less than 0.1-0.5%). This high accuracy provides greater confidence in the screening results compared to traditional methods.
• Non-Invasive Nature: NIPT requires only a simple blood draw from the mother. This makes it exceptionally safe for both the mother and the developing baby, carrying no risk of miscarriage associated with invasive diagnostic procedures like amniocentesis or CVS.
• Early Detection Option: NIPT can be performed as early as 10 weeks of gestation. This early insight allows more time for decision-making, further testing if needed, and emotional and practical preparation.
• Reduced Need for Invasive Diagnostic Tests: Due to its high accuracy and low false-positive rate, a low-risk NIPT result can significantly reduce the number of women who might otherwise be recommended for invasive diagnostic testing based on traditional screening or age alone. This helps avoid the small but present risks associated with such procedures.
• Provides Reassurance or Early Information for Planning: For many expectant parents, a low-risk NIPT result provides significant reassurance, alleviating anxiety. In cases of a high-risk result, while it necessitates further discussion and diagnostic testing, it provides early critical information, allowing parents and healthcare providers to plan for potential outcomes and specialized care if required.

Understanding these "pros" is an important part of evaluating the overall NIPT pros and cons. The information gained from a NON INVASIVE PRENATAL TESTING (NIPT) can empower you to make informed choices throughout your pregnancy.

It's vital to reiterate that NON INVASIVE PRENATAL TESTING (NIPT) Screens for conditions; it does not diagnose them. A high-risk NIPT result indicates an increased probability and requires confirmation through diagnostic testing.

The primary conditions that NIPT effectively screens for include:

• Trisomy 21 (Down syndrome): This is the most common chromosomal abnormality, caused by an extra copy of chromosome 21.
• Trisomy 18 (Edwards syndrome): Caused by an extra copy of chromosome 18, this condition is associated with severe health problems.
• Trisomy 13 (Patau syndrome): Caused by an extra copy of chromosome 13, this condition also leads to serious health issues.

When considering what does non invasive prenatal testing screen for, it’s important to know that many NIPT panels offered by labs like Cadabams Diagnostics may also include screening for:

• Sex Chromosome Aneuploidies (SCAs): These are conditions caused by an abnormal number of X or Y chromosomes. Examples include:
• Turner syndrome (Monosomy X)
• Klinefelter syndrome (XXY)
• Triple X syndrome (XXX)
• Jacobs syndrome (XYY)
• Fetal Sex: NIPT can also predict the sex of the baby with high accuracy if desired.
• Microdeletion Syndromes (Optional): Some NIPT panels may extend to screen for certain microdeletion syndromes (e.g., DiGeorge syndrome, Cri-du-chat syndrome), though the accuracy for these can be more variable than for common trisomies.

Early knowledge that NIPT can initiate (pending diagnostic confirmation) can be invaluable. It allows parents to prepare thoughtfully and access resources. For instance, should a condition be confirmed that might be associated with different developmental pathways, families can begin to learn about concepts like neurodiversity. This understanding can help in planning for potential future needs, which might include specialized support like pediatric therapy or early interventions focused on sensory integration, ensuring the child receives the best possible start and ongoing care. Your doctor at Cadabams Diagnostics can discuss the specific conditions covered by the NIPT panel you are considering.

Preparing for your NON INVASIVE PRENATAL TESTING (NIPT) at Cadabams Diagnostics is generally straightforward. Here’s what you need to know:

Instructions:

• Dietary Restrictions: Usually, no special dietary restrictions are required. You typically do not need to fast before the NIPT blood draw.
• Hydration: Staying well-hydrated by drinking plenty of water can make the blood draw easier.
• Requisition Form: Bring the requisition form or referral from your healthcare provider if you have one.

Prerequisites:

• Consultation: It is highly recommended, and often required, to have a consultation with your healthcare provider (obstetrician, midwife) or a genetic counselor before undergoing NIPT. This session is crucial to discuss the test's purpose, what it screens for, its limitations, the meaning of potential results, and the overall NIPT pros and cons. This ensures you are making an informed decision. You can discuss your options with experts at or seek a referral
• Informed Consent: You will be asked to provide informed consent, indicating that you understand the test and agree to have it performed.

Eligibility:

• Gestational Age: NIPT is generally suitable for pregnancies from 10 weeks of gestation onwards.
• Pregnancy Type: It is typically validated for singleton (one baby) and many twin pregnancies. For higher-order multiple pregnancies (triplets or more), or for certain complex twin pregnancies (e.g., with a vanished twin), the suitability and interpretation may need careful consideration with your provider.
• Specific Criteria: Cadabams Diagnostics may have specific eligibility criteria; please confirm with our staff or your referring doctor.

NIPT test procedure step by step:

The actual procedure for the NON INVASIVE PRENATAL TESTING (NIPT) is simple:

1. Brief Counselling/Information Check (if not already extensively covered): The staff at Cadabams Diagnostics may briefly review the test with you and answer any last-minute questions.

2. Blood Draw: A qualified phlebotomist will collect a small sample of blood from a vein in your arm, similar to any routine blood test.

3. Sample Processing: The blood sample is then carefully labeled and sent to our specialized laboratory for analysis of the cell-free DNA.

4. Analysis and Reporting: Lab technicians will analyze the cfDNA to assess the risk for the specified chromosomal conditions. Results are typically available within a specified turnaround time (see FAQ).

The blood draw itself usually takes only a few minutes.

Caution Before the Test:

Before your blood is drawn for the NON INVASIVE PRENATAL TESTING (NIPT), please inform the Cadabams Diagnostics staff or your healthcare provider if:

• You have any bleeding disorders or are taking blood-thinning medications (e.g., aspirin, heparin, warfarin).
• You are pregnant with more than one baby (e.g., twins, triplets). Please confirm the number of fetuses.
• Your pregnancy was conceived via In Vitro Fertilization (IVF), especially if an egg donor or sperm donor was used, or if preimplantation genetic testing (PGT) was performed on the embryos. This information can be relevant for interpreting the NIPT results.